Skip to main content
SpringerLink
Log in

Ischemic Peripheral Retinopathies

  • Chapter
  • First Online:
Retina Lasers in Ophthalmology

  • 251 Accesses

Abstract

Laser photocoagulation of the retina is applied in a group of clinical entities very different in their etiology but sharing one most important characteristic: they present with areas of peripheral hypoperfusion. As the goals and the technique of treatment are alike in those cases, we decided to characterize them in one chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. The Central Vein Occlusion Study Group A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion: the Central Retinal Vein Occlusion Study Group N Report. Ophthalmology. 1995;102:1434–44.

    Google Scholar 

  2. Stefansson E. The mechanism of retinal photocogulation—how does the laser work? Eur Ophthalmic Rev. 2008;2:?

    Google Scholar 

  3. Pournaras CJ. Retinal oxygen distribution Its role in the physiopathology of vasoproliferative microangiopathies. Retina. 1995;15:332–47.

    Article  CAS  PubMed  Google Scholar 

  4. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The diabetic retinopathy study research group. Ophthalmology. 1981;88(7):583–600

    Google Scholar 

  5. Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion A randomized clinical trial. Arch Ophthalmol. 1986;104:34–41.

    Article  Google Scholar 

  6. Schnog JB, Duits AJ, Muskiet FA, ten Cate H, Rojer RA, Brandjes DP. Sickle cell disease; a general overview. Neth J Med. 2004;62(10):364–74.

    CAS  PubMed  Google Scholar 

  7. Jackson H, Bentley CR, Hingorani M, Atkinson P, Aclimandos WA, Thompson GM. Sickle retinopathy in patients with sickle trait. Eye (Lond). 1995;9(Pt 5):589–93.

    Article  PubMed  Google Scholar 

  8. Goldberg MF. Classification and pathogenesis of proliferative sickle retinopathy. Am J Ophthalmol. 1971;71(3):649–65.

    Article  CAS  PubMed  Google Scholar 

  9. Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312:1033–48.

    Article  PubMed  Google Scholar 

  10. Li J, Bender L, Shaffer J, et al. Prevalence and onset of pediatric sickle cell retinopathy. Ophthalmology. 2019;126:1000–6.

    Article  PubMed  Google Scholar 

  11. Ahmed I, Pradeep T, Goldberg MF, Liu TYA, Aradhya A, Montana MP, Photiadis N, Williams E, Smith B, Tian J, Lanzkron SM, Scott AW. Nonmydriatic ultra-widefield fundus photography in a hematology clinic shows utility for screening of sickle cell retinopathy. Am J Ophthalmol. 2022;236:241–8.

    Article  PubMed  Google Scholar 

  12. Downes SM, Hambleton IR, Chuang EL, et al. Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study. Ophthalmology. 2005;112:1869–75.

    Article  PubMed  Google Scholar 

  13. Farber MD, Jampol LM, Fox P, et al. A randomized clinical trial of scatter photocoagulation of proliferative sickle cell retinopathy. Arch Ophthalmol. 1991;109:363–7.

    Article  CAS  PubMed  Google Scholar 

  14. Myint KT, Sahoo S, Thein AW, Moe S, Ni H. Laser therapy for retinopathy in sickle cell disease. Cochrane Database Syst Rev. 20159;2015(10):CD010790.

    Google Scholar 

  15. Rodrigues M, Kashiwabuchi F, Deshpande M, Jee K, Goldberg MF, Lutty G, Semenza GL, Montaner S, Sodhi A. Expression pattern of HIF-1α and VEGF supports circumferential application of scatter laser for proliferative sickle retinopathy. Invest Ophthalmol Vis Sci. 2016;57(15):6739–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Cai CX, Linz MO, Scott AW. Intravitreal bevacizumab for proliferative sickle retinopathy: a case series. J of VitRet Dis. 2018;2:32–8.

    Google Scholar 

  17. Chen RWS, Flynn HW, Lee WH, et al. Vitreoretinal management and surgical outcomes in proliferative sickle retinopathy: a case series. Am J Ophthalmol. 2014;157:870-875.e1.

    Article  PubMed  Google Scholar 

  18. Rosenbaum JT, Ku J, Ali A, Choi D, Suhler EB. Patients with retinal vasculitis rarely suffer from systemic vasculitis. Semin Arthritis Rheum. 2012;41(6):859–65.

    Article  PubMed  Google Scholar 

  19. Hughes EH, Dick AD. The pathology and pathogenesis of retinal vasculitis. Neuropathol Appl Neurobiol. 2003;29(4):325–40. https://doi.org/10.1046/j.1365-2990.2003.00499.x. PMID: 12887593.

  20. Graham EM, Stanford MR, Sanders MD, Kasp E, Dumonde DC. A point prevalence study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features. Br J Ophthalmol. 1989;73(9):714–21.

    Google Scholar 

  21. Sharief L, Lightman S, Blum-Hareuveni T, Bar A, Tomkins-Netzer O. Clinical outcome of retinal vasculitis and predictors for prognosis of ischemic retinal vasculitis. Am J Ophthalmol. 2017;177:206–12.

    Article  PubMed  Google Scholar 

  22. Agarwal A, Rübsam A, Zur Bonsen L, Pichi F, Neri P, Pleyer U. A comprehensive update on retinal vasculitis: etiologies, manifestations and treatments. J Clin Med. 2022;11(9):2525.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Shukla D, Kalliath J, Dhawan A. Tubercular retinal vasculitis: diagnostic dilemma and management strategies. Clin Ophthalmol. 2021;15:4681–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Pan SW, Yusof NS, Hitam WH, Noor RA, Embong Z. Syphilitic uveitis: report of 3 cases. Int J Ophthalmol. 2010;3(4):361–4.

    PubMed  PubMed Central  Google Scholar 

  25. Smith JL, Winward KE, Nicholson DF, Albert DW. Retinalvasculitis in Lyme borreliosis. J Clin Neuro-Ophthalmol. 1991;11:7–15.

    Google Scholar 

  26. Mora P, Carta A. Ocular manifestations of Lyme borreliosis in Europe. Int J Med Sci. 2009;6(3):124–5.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Avila MP, Jalkh AE, Feldman E, Trempe CL, Schepens CL. Manifestations of Whipple’s disease in the posterior segment of the eye. Arch Ophthalmol. 1984;102(3):384–90.

    Article  CAS  PubMed  Google Scholar 

  28. Bazzazi N, Yavarikia A, Keramat F. Ocular involvement of brucellosis. Middle East Afr J Ophthalmol. 2013;20(1):95–7.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Tolou C, Mahieu L, Martin-Blondel G, Ollé P, Matonti F, Hamid S, Benouaich X, Debard A, Cassagne M, Soler V. Posterior segment involvement in cat-scratch disease: a case series. J Fr Ophtalmol. 2015;38(10):974–82.

    Article  CAS  PubMed  Google Scholar 

  30. Albert K, Masset M, Bonnet S, Willermain F, Caspers L. Long-term follow-up of herpetic non-necrotizing retinopathy with occlusive retinal vasculitis and neovascularization. J Ophthalmic Inflamm Infect. 2015;28(5):6.

    Article  Google Scholar 

  31. Narayanan S, Gopalakrishnan M, Giridhar A, Anthony E. Varicella Zoster-related Occlusive Retinal Vasculopathy–A Rare Presentation. Ocul Immunol Inflamm. 2016;24(2):227–30.

    PubMed  Google Scholar 

  32. Merle H, Hage R, Meniane JC, Deligny C, Plumelle Y, Donnio A, Jean-Charles A. Retinal manifestations in adult t-cell leukemia/lymphoma related to infection by the human t-cell lymphotropic virus type-1. Retina. 2016;36(7):1364–71.

    Article  CAS  PubMed  Google Scholar 

  33. Siam AL, Meegan JM, Gharbawi KF. Rift valley fever ocular manifestations: observations during the 1977 epidemic in Egypt. Br J Ophthalmol. 1980;64(5):366–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Roth DB, McCabe CM, Davis JL. HIV-related occlusive vasculitis. Arch Ophthalmol. 1999;117(5):696–8.

    Article  CAS  PubMed  Google Scholar 

  35. Garg S, Jampol LM, Wilson JF, Batlle IR, Buettner H. Ischemic and hemorrhagic retinal vasculitis associated with West Nile virus infection. Retina. 2006;26(3):365–7.

    Article  PubMed  Google Scholar 

  36. Mayer CS, Blobner K, Storr J, Baur ID, Khoramnia R. Acute retinal necrosis: signs, treatment, complications and outcome. Diagnostics (Basel). 2022;12(2):386.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Tseng CC, Chen SN, Hwang JF, Lin CJ, Chen HS. Progressive outer retinal necrosis associated with occlusive vasculitis in acquired immunodeficiency syndrome. J Formos Med Assoc. 2015;114(5):469–72.

    Article  PubMed  Google Scholar 

  38. Downes KM, Tarasewicz D, Weisberg LJ, Cunningham ET Jr. Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients-case report and comprehensive review of the literature. J Ophthalmic Inflamm Infect. 2016;6(1):3.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Suzuki K, Namba K, Hase K, Mizuuchi K, Iwata D, Ito T, Kitaichi N, Takase H, Ishida S. A case of Epstein-Barr virus acute retinal necrosis successfully treated with foscarnet. Am J Ophthalmol Case Rep. 2022;29(25): 101363.

    Article  Google Scholar 

  40. Nordstrom B, Sherpa N, Marshall M, Chawla A, Heidari A, Johnson R. Coccidioidomycosis Chorioretinitis. J Investig Med High Impact Case Rep. 2019;7:2324709619881561.

    PubMed  PubMed Central  Google Scholar 

  41. Vinekar A, Avadhani K, Maralusiddappa P, Prabhu VM, Mahendradas P, Indumathi VA. Retinal vasculitis as an early indicator of systemic candidal abscesses in a premature infant. J AAPOS. 2011;15(1):96–7.

    Article  PubMed  Google Scholar 

  42. Butler NJ, Furtado JM, Winthrop KL, Smith JR. Ocular toxoplasmosis II: clinical features, pathology and management. Clin Exp Ophthalmol. 2013;41(1):95–108.

    Google Scholar 

  43. Despreaux R, Fardeau C, Touhami S, Brasnu E, Champion E, Paris L, Touitou V, Bodaghi B, Lehoang P. Ocular toxocariasis: clinical features and long-term visual outcomes in adult patients. Am J Ophthalmol. 2016;166:162–8.

    Article  PubMed  Google Scholar 

  44. Shi L, Hager T, Fries FN, Daas L, Holbach L, Hofmann-Rummelt C, Zemova E, Seitz B, Szentmáry N. Reactive uveitis, retinal vasculitis and scleritis as ocular end-stage of Acanthamoeba keratitis: a histological study. Int J Ophthalmol. 2019;12(12):1966–71.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Beselga D, Campos A, Castro M, Mendes S, Campos J, Neves A, Violante L, Castro Sousa JP. A rare case of retinal artery occlusion in the context of mediterranean spotted fever. Case Rep Ophthalmol. 2014;5(1):22–7.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Atmaca LS, Idil A, Gündüz K. Visualization of retinal vasculitis in Eales’ disease. Ocul Immunol Inflamm. 1993;1(1–2):41–8.

    Article  CAS  PubMed  Google Scholar 

  47. Ozdal PC, Berker N, Tugal-Tutkun I. Pars Planitis: epidemiology, clinical characteristics, management and visual prognosis. J Ophthalmic Vis Res. 2015;10(4):469–80.

    Google Scholar 

  48. Knickelbein JE, Tucker W, Kodati S, Akanda M, Sen HN. Non-invasive method of monitoring retinal vasculitis in patients with birdshot chorioretinopathy using optical coherence tomography. Br J Ophthalmol. 2018;102(6):815–20.

    Article  PubMed  Google Scholar 

  49. Arellanes-García L, Hernández-Barrios M, Fromow-Guerra J, Cervantes-Fanning P. Fluorescein fundus angiographic findings in Vogt-Koyanagi-Harada syndrome. Int Ophthalmol. 2007;27(2–3):155–61.

    Google Scholar 

  50. Bajgai P, Katoch D, Dogra MR, Singh R. Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: clinical perspectives. Clin Ophthalmol. 2017;6(11):1805–17.

    Article  Google Scholar 

  51. Johnson MW, Thomley ML, Huang SS, Gass JD. Idiopathic recurrent branch retinal arterial occlusion Natural history and laboratory evaluation. Ophthalmology. 1994;101(3):480–9.

    Article  CAS  PubMed  Google Scholar 

  52. Blumenkranz MS, Kaplan HJ, Clarkson JG, Culbertson WW, Williams GA, Kleiner RC, Meissner RH. Acute multifocal hemorrhagic retinal vasculitis. Ophthalmology. 1988;95(12):1663–72.

    Article  CAS  PubMed  Google Scholar 

  53. Davatchi F, Chams-Davatchi C, Shams H, Shahram F, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Sadeghi Abdollahi B, Ashofteh F, Mohtasham N, Kavosi H, Masoumi M. Behcet’s disease: epidemiology, clinical manifestations, and diagnosis. Expert Rev Clin Immunol. 2017;13(1):57–65.

    Article  CAS  PubMed  Google Scholar 

  54. Bypareddy R, Takkar B, Azad SV, Chawla R, Venkatesh P. Optic nerve head granuloma, retinal vasculitis and elevated levels of angiotensin-converting enzyme: dilemma of forme fruste ocular sarcoidosis. J Ophthalmic Vis Res. 2019;14(1):105–108.

    Google Scholar 

  55. Matlach J, Freiberg FJ, Gadeholt O, Göbel W. Vasculitis-like hemorrhagic retinal angiopathy in Wegener’s granulomatosis. BMC Res Notes. 2013;10(6):364.

    Article  Google Scholar 

  56. Chen XH, Shi JC, Wei JC, Chen HH, Mo HY. Increased risk of retinal vasculitis in patients with systemic lupus erythematosus: a nationwide population-based cohort study. Front Med (Lausanne). 2021;28(8): 739883.

    Article  Google Scholar 

  57. Paroli MP, Priori R, Spinucci G, Abicca I, Valesini G. Uveitis with retinal occlusive vasculitis and sensorineural hypoacusia as first symptoms of relapsing polychondritis. Clin Exp Rheumatol. 2012;30(1 Suppl 70):S101–3.

    Google Scholar 

  58. Bajgai P, Singh R. Retinal vasculitis in Takayasu’s arteritis. N Engl J Med. 2018;378(21): e28.

    Article  PubMed  Google Scholar 

  59. Morgan CM, Foster CS, D'Amico DJ, Gragoudas ES. Retinal vasculitis in polyarteritis nodosa. Retina. 1986 Winter;6(4):205–9.

    Google Scholar 

  60. Garcia-Diaz M, Mira M, Nevado L, Galván A, Berenguer A, Bureo JC. Retinal vasculitis associated with Crohn’s disease. Postgrad Med J. 1995;71(833):170–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Watanabe T, Marumo Y, Ishizu A. Retinal vasculitis in primary Sjögren’s syndrome. Rheumatology (Oxford). 2019;58(7):1244.

    Article  PubMed  Google Scholar 

  62. Turk MA, Hayworth JL, Nevskaya T, Pope JE. Ocular manifestations in rheumatoid arthritis, connective tissue disease, and vasculitis: a systematic review and metaanalysis. J Rheumatol. 2021;48(1):25–34.

    Article  PubMed  Google Scholar 

  63. Backhouse O, Griffiths B, Henderson T, Emery P. Ophthalmic manifestations of dermatomyositis. Ann Rheum Dis. 1998;57(8):447–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. AlBloushi AF, Dheyab AM, Al-Swaina NF, Al-Obailan M, Daif AK, Abu El-Asrar AM. Clinical findings and outcomes of uveitis associated with multiple sclerosis. Eur J Ophthalmol. 2021;31(2):482–90.

    Article  PubMed  Google Scholar 

  65. Szydełko-Paśko U, Przeździecka-Dołyk J, Małecki R, Szuba A, Misiuk-Hojło M. Ocular manifestations of Buerger’s disease—a review of current knowledge. Clin Ophthalmol. 2022;18(16):851–60.

    Article  Google Scholar 

  66. Trese MGJ, Yonekawa Y, Thomas BJ, Randhawa S. Vasculitic central retinal vein occlusion: the presenting sign of seronegative rheumatoid arthritis. Am J Ophthalmol Case Rep. 2016;18(2):26–9.

    Article  Google Scholar 

  67. Akella SS, Schlachter DM, Black EH, Barmettler A. Ophthalmic eosinophilic granulomatosis with polyangiitis (Churg-Strauss Syndrome): a systematic review of the literature. Ophthalmic Plast Reconstr Surg. 2019;35(1):7–16.

    Google Scholar 

  68. Braakenburg AM, Rothova A. The clinical characteristics of retinal vasculitis in HLA-B27-positive patients. Ocul Immunol Inflamm. 2014;22(3):197–202.

    Article  CAS  PubMed  Google Scholar 

  69. Lally L, Sammaritano LR. Vasculitis in antiphospholipid syndrome. Rheum Dis Clin North Am. 2015;41(1):109–23.

    Article  PubMed  Google Scholar 

  70. Sonne SJ, Shieh WS, Srivastava SK, Smith BT. Lymphoma masquerading as occlusive retinal vasculitis: a case study. Am J Ophthalmol Case Rep. 2020;10(19): 100777.

    Article  Google Scholar 

  71. Ksiaa I, Kechida M, Zina S, Lahdhiri M, Abroug N, Khairallah M. Acute lymphoblastic leukemia relapse presenting as retinal vasculitis. Clin Case Rep. 2020;8(8):1467–71.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Anastasakis A, Dick AD, Damato EM, Spry PG, Majid MA. Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction. Doc Ophthalmol. 2011;123(1):59–63.

    Article  PubMed  Google Scholar 

  73. Suzuki T, Obara Y, Sato Y, Saito G, Ichiwata T, Uchiyama T. Cancer-associated retinopathy with presumed vasculitis. Am J Ophthalmol. 1996;122(1):125–7.

    Article  CAS  PubMed  Google Scholar 

  74. Agarwal A. Retinal vasculitis. https://eyewiki.aao.org/Retinal_Vasculitis.

  75. Manousaridis K, Ong E, Stenton C, Gupta R, Browning AC, Pandit R. Clinical presentation, treatment, and outcomes in presumed intraocular tuberculosis: experience from Newcastle upon Tyne, UK. Eye. 2013;27(4):480–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Al-Mezaine HS, Al-Muammar A, Kangave D, Abu El-Asrar AM. Clinical and optical coherence tomographic findings and outcome of treatment in patients with presumed tuberculous uveitis. Int Ophthalmol. 2008;28(6):413–423.

    Google Scholar 

  77. Yuksel E, Ozdek S. Unusual presentation of ocular tuberculosis: multiple chorioretinitis, retinal vasculitis and ischaemic central retinal vein occlusion. Clin Exp Optom. 2013;96(4):428–9.

    Article  PubMed  Google Scholar 

  78. Gupta V, Gupta A, Rao NA. Intraocular tuberculosisan update. Surv Ophthalmol. 2007;52(6):561–87.

    Article  PubMed  Google Scholar 

  79. Das T, Pathengay A, Hussain N, Biswas J. Eales’ disease: diagnosis and management. Eye (Lond). 2010;24(3):472–82.

    Article  CAS  PubMed  Google Scholar 

  80. Murthy KR, Abraham C, Baig SM, Badrinath SS. Eales’ disease. Proc All lnd Ophthalmol Soc. 1977;33:323.

    Google Scholar 

  81. Renie WA, Murphy RP, Anderson KC, et al. The evaluation of patients with Eales’ disease. Retina. 1983;3:243–8.

    Article  CAS  PubMed  Google Scholar 

  82. Verma A, Biswas J, Dhanurekha L, Gayathri R, Lily TK. Detection of Mycobacterium tuberculosis with nested polymerase chain reaction analysis in enucleated eye ball in Eales’ disease. Int Ophthalmol. 2016;36(3):413–7.

    Article  PubMed  Google Scholar 

  83. Goel N, Kumar V, Arora S, Jain P, Ghosh B. Spectral domain optical coherence tomography evaluation of macular changes in Eales disease. Indian J Ophthalmol. 2018;66(3):433–8.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Saxena S, Kumar D. A new staging system for idiopathic retinal periphlebitis. Eur J Ophthalmol. 2004;14(3):236–9.

    Article  CAS  PubMed  Google Scholar 

  85. Biswas J, Ravi RK, Naryanasamy A, Kulandai LT, Madhavan HN. Eales’ disease—current concepts in diagnosis and management. J Ophthalmic Inflamm Infect. 2013;3(1):11.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Ishaq M, Feroze AH, Shahid M, Baig MA, Ameen SS, Feroze SH, et al. Intravitreal steroids may facilitate treatment of Eales’ disease (idiopathic retinal vasculitis): an interventional case series. Eye. 2007;21:1403–5.

    Article  CAS  PubMed  Google Scholar 

  87. Patwardhan SD, Azad R, Shah BM, Sharma Y. Role of intravitreal bevacizumab in Eales disease with dense vitreous hemorrhage: a prospective randomized control study. Retina. 2011;31:866–70.

    Article  CAS  PubMed  Google Scholar 

  88. Chanana B, Azad RV, Patwardhan S. Role of intravitreal bevacizumab in the management of Eales’ disease. Int Ophthalmol. 2010;30:57–61.

    Article  PubMed  Google Scholar 

  89. El-Asrar AM, Al-Kharashi SA. Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales’ disease). Br J Ophthalmol. 2002;86(11):1248–51.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Ishaq M, Niazi MK. Usefulness of laser photocoagulation in managing asymptomatic eyes of Eales disease. J Ayub Med Coll Abbottabad. 2002;14(4):22–32.

    PubMed  Google Scholar 

  91. Gopal L, Abraham C. Efficacy of photocoagulation in Eales’ disease. Trans Asia-Pacific Acad. 1985;10:689.

    Google Scholar 

  92. Das TP, Namperumalsamy P. Photocoagulation in Eales’ disease. Results of prospective randomised clinical study. Presented in XXVI International Congress of Ophthalmology. Singapore; 1990. (gdzie to bylo opublikowane?).

    Google Scholar 

  93. Shukla D, Kanungo S, Prasad NM, Kim R. Surgical outcomes for vitrectomy in Eales’ disease. Eye. 2008;22:900–4.

    Article  CAS  PubMed  Google Scholar 

  94. Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol. 1986;102:297–301.

    Article  CAS  PubMed  Google Scholar 

  95. Obenauf CD, Shaw HE, Sydnor CF, Klintworth GK. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol. 1978;86:648–55.

    Article  CAS  PubMed  Google Scholar 

  96. Ungprasert P, Tooley AA, Crowson CS, Matteson EL, Smith WM. Clinical characteristics of ocular sarcoidosis: a population-based study 1976–2013. Ocul Immunol Inflamm. 2017;27(3):389–95.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Matsou A, Tsaousis KT. Management of chronic ocular sarcoidosis: challenges and solutions. Clin Ophthalmol. 2018;12:519–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Lobo A, Barton K, Minassian D, Du Bois RM, Lightman S. Visual loss in sarcoid-related uveitis. Clin Exp Ophthalmol. 2003;31(4):310–6.

    Article  PubMed  Google Scholar 

  99. Jabs DA, Fine SL, Hochberg MC, Newman SA, Heiner GG, Stevens MB. Severe retinal vaso-occlusive disease in systemic lupus erythematosus. Arch Ophthalmol. 1986;104:558–63.

    Article  CAS  PubMed  Google Scholar 

  100. Asherson RA, Merry P, Acheson JF, Harris EN, Hughes GR. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the ‘primary’ antiphospholipid syndrome. Ann Rheum Dis. 1989;48(5):358–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Klinkhoff AV, Beattie CW, Chalmers A. Retinopathy in systemic lupus erythematosus: relationship to disease activity. Arthritis Rheum. 1986;29(9):1152–1156.

    Google Scholar 

  102. Au A, O’Day J. Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Exp Ophthalmol. 2004;32(1):87–100.

    Article  PubMed  Google Scholar 

  103. Lee WJ, Cho HY, Lee YJ, Lee BR, Shin JP. Intravitreal bevacizumab for severe vaso-occlusive retinopathy in systemic lupus erythematosus. Rheumatol Int. 2013;33(1):247–51.

    Article  CAS  PubMed  Google Scholar 

  104. Dammacco R. Systemic lupus erythematosus and ocular involvement: an overview. Clin Exp Med. 2018;18(2):135–49.

    Article  CAS  PubMed  Google Scholar 

  105. Jeon S, Lee WK. Aggravated capillary non-perfusion after intravitreal bevacizumab for macular edema secondary to systemic lupus erythematosus and anti-phospholipid syndrome. Lupus. 2012;21(3):335–7.

    Article  CAS  PubMed  Google Scholar 

  106. Uludag G, Onghanseng N, Tran ANT, et al. Current concepts in the diagnosis and management of antiphospholipid syndrome and ocular manifestations. J Ophthal Inflamm Infect. 2021;11:11.

    Article  CAS  Google Scholar 

  107. Cobo-Soriano R, S´anchez-Ram´on S, Aparicio MJ et al. Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study. Am J Ophthalmol 1999;128(6):725–732.

    Google Scholar 

  108. Durrani OM, Gordon C, Murray PI. Primary anti-phospholipid antibody syndrome (APS): current concepts. Surv Ophthalmol. 2002;47(3):215–38.

    Article  PubMed  Google Scholar 

  109. Utz VM, Tang J. Ocular manifestations of the antiphospholipid syndrome. Br J Ophthalmol. 2011;95(4):454–9.

    Article  PubMed  Google Scholar 

  110. Lima Cabrita FV, Foster CS. Anticardiolipin antibodies and ocular disease. Ocul Immunol Inflamm. 2005;13(4):265–70.

    Article  PubMed  Google Scholar 

  111. Zhu W, Wu Y, Xu M, Wang JY, Meng YF, Gu Z, Lu J. Antiphospholipid antibody and risk of retinal vein occlusion: a systematic review and meta-analysis. PLoS ONE. 2014;10(4): e0122814.

    Article  PubMed  Google Scholar 

  112. Miserocchi E, Baltatzis S, Foster CS. Ocular features associated with anticardiolipin antibodies: a descriptive study. Am J Ophthalmol. 2001;131(4):451–6.

    Article  CAS  PubMed  Google Scholar 

  113. Chighizola CB, Ubiali T, Meroni PL. Treatment of thrombotic Antiphospholipid syndrome: the rationale of current management-an insight into future approaches. J Immunol Res. 2015:951424.

    Google Scholar 

  114. International Study Group for Behcet’s Disease. Criteria for diagnosis of Behcet’s disease. Lancet. 1990;335:1078–80.

    Google Scholar 

  115. Ho T-Y, Chung Y-M, Lee A-F, Tsai C-Y. Severe vasoocclusive retinopathy as the primary manifestation in a patient with systemic lupus erythematosus. J Chin Med Assoc. 2008;71(7):377–80.

    Article  PubMed  Google Scholar 

  116. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Kir N, Urgancioglu M. Neovascularization of the optic disc in Behcet’s disease. Jpn J Ophthalmol. 2006;50(3):256–65.

    Article  PubMed  Google Scholar 

  117. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M. Uveitis in Behcet disease: an analysis of 880 patients. Am J Ophthalmol 2004;138(3):373–380.

    Google Scholar 

  118. Atmaca LS, Batioğlu F, Idil A. Retinal and disc neovascularization in Behçet’s disease and efficacy of laser photocoagulation. Graefes Arch Clin Exp Ophthalmol. 1996;234(2):94–9.

    Article  CAS  PubMed  Google Scholar 

  119. Brown GC, Magargal LE. The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features. Int Ophthalmol. 1988;11(4):239–251.

    Google Scholar 

  120. Biousse V. Carotid disease and the eye. Curr Opin Ophthalmol. 1997;8(6):16–26.

    Article  CAS  PubMed  Google Scholar 

  121. Mizener JB, Podhajsky P, Hayreh SS. Ocular ischemic syndrome. Ophthalmology. 1997;104(5):859–64.

    Article  CAS  PubMed  Google Scholar 

  122. Fattahi TT, Brandt MT, Jenkins WS, Steinberg B. Traumatic Carotid-Cavernous Fistula: Pathophysiology and Treatment. J Craniofac Surg. 2003;14(2):240.

    Article  PubMed  Google Scholar 

  123. Ellis JA, Goldstein H, Connolly ES, Meyers PM. Carotid-cavernous fistulas. Neurosurg Focus 2012;32(5).

    Google Scholar 

  124. Komiyama M, Yamanaka K, Nagata Y, Ishikawa H. Dural carotid-cavernous sinus fistula and central retinal vein occlusion: a case report and a review of the literature. Surg Neurol. 1990;34(4):255–9.

    Article  CAS  PubMed  Google Scholar 

  125. Suzuki Y, Kase M, Yokoi M, Arikado T, Miyasaka K. Development of central retinal vein occlusion in dural carotid-cavernous fistula. Ophthalmologica. 1989;199(1):28–33.

    Article  CAS  PubMed  Google Scholar 

  126. Barke RM, Yoshizumi MO, Hepler RS, Krauss HR, Jabour BA. Spontaneous dural carotid-cavernous fistula with central retinal vein occlusion and iris neovascularization. Ann Ophthalmol. 1991;23(1):11–7.

    CAS  PubMed  Google Scholar 

  127. Harris MJ, Fine SL, Miller NR. Photocoagulation treatment of proliferative retinopathy secondary to a carotid-cavernous fistula. Am J Ophthalmol. 1980;90(4):515–8.

    Article  CAS  PubMed  Google Scholar 

  128. Kalina RE, Kelly WA. Proliferative retinopathy after treatment of carotid-cavernous fistulas. Arch Ophthalmol. 1978;96(11):2058–60.

    Article  CAS  PubMed  Google Scholar 

  129. Stryjewski TP, Papakostas TD, Vavvas D. Proliferative hypertensive retinopathy. JAMA Ophthalmol. 2016;134(3):345–6.

    Article  PubMed  Google Scholar 

  130. Abu Sbeit RHS, Mohammed OA, Alamlih LI. Hypertension as an unusual cause of proliferative retinopathy: case report and literature review. Case Rep Ophthalmol. 2021;12(2):594–602.

    Article  PubMed  PubMed Central  Google Scholar 

  131. Konstantinidis L, Guex-Crosier Y. Hypertension and the eye. Curr Opin Ophthalmol. 2016;27(6):514–21.

    Article  PubMed  Google Scholar 

  132. Avila SA, Golshani C, Friedman AH. Hypertensive crisis with massive retinal and choroidal infarction: a case update. Am J Ophthalmol Case Rep. 2019;13:22–4.

    Article  PubMed  Google Scholar 

  133. Georgiadis O, Kabanarou SA, Batsos G, Feretis E, Xirou T. Bilateral hypertensive retinopathy complicated with retinal neovascularization: panretinal photocoagulation or intravitreal anti-VEGF treatment? Case Rep Ophthalmol. 2014;5(2):231–8.

    Article  PubMed  PubMed Central  Google Scholar 

  134. Annesley WH Jr. Peripheral exudative hemorrhagic chorioretinopathy. Trans Am Ophthalmol Soc. 1980;78:321–64.

    Google Scholar 

  135. Vandefonteyne S, Caujolle JP, Rosier L, Conrath J, Quentel G, Tadayoni R, Maschi C, Le Mer Y, Dot C, Aknin I, Thariat J, Baillif S. Diagnosis and treatment of peripheral exudative haemorrhagic chorioretinopathy. Br J Ophthalmol. 2020;104(6):874–8.

    Article  PubMed  Google Scholar 

  136. Shields CL, Salazar PF, Mashayekhi A, Shields JA. Peripheral exudative hemorrhagic chorioretinopathy simulating choroidal melanoma in 173 eyes. Ophthalmology. 2009;116:529–35.

    Article  PubMed  Google Scholar 

  137. Huang J, Gajewski A, Cesaro T, Messina C, Mega JV Jr, Sellechio J. Peripheral exudative hemorrhagic chorioretinopathy in patients with nonexudative age-related macular degeneration. Fed Pract. 2017;34(5):20–2.

    CAS  PubMed  PubMed Central  Google Scholar 

  138. Alforja MS, Sabater N, Giralt J, Adán A, Pelegrín L, Casaroli-Marano R. Intravitreal bevacizumab injection for peripheral exudative hemorrhagic chorioretinopathy. Jpn J Ophthalmol. 2011;55:425–7.

    Article  PubMed  Google Scholar 

  139. Kumar V, Tewari R. Giant retinal pigment epithelium rip in a patient with peripheral exudative hemorrhagic chorioretinopathy. Indian J Ophthalmol. 2019;67:1164–5.

    Article  PubMed  PubMed Central  Google Scholar 

  140. Badawi AH, Semidey VA, Magliyah M, Al-Dhibi H. Updated systematic review and clinical spectrum of peripheral exudative hemorrhagic chorioretinopathy. Middle East Afr J Ophthalmol. 2020;27(1):4–9.

    Article  PubMed  PubMed Central  Google Scholar 

  141. Avashia JH, Fath DF. Bilateral central retinal vein occlusion in Waldenström’s macroglobulinemia. J Am Optom Assoc. 1989;60(9):657–8.

    CAS  PubMed  Google Scholar 

  142. Feman SS, Stein RS. Waldenstrom’s macroglobulinemia, a hyperviscosity manifestation of venous stasis retinopathy. Int Ophthalmol. 1981;4(1–2):107–12.

    Article  CAS  PubMed  Google Scholar 

  143. Menke MN, Feke GT, McMeel JW, Branagan A, Hunter Z, Treon SP. Hyperviscosity-related retinopathy in waldenstrom macroglobulinemia. Arch Ophthalmol. 2006;124(11):1601–6.

    Article  PubMed  Google Scholar 

  144. Omoti AE, Omoti CE. Ophthalmic Manifestations of Multiple Myeloma. West Afr J Med. 2007;26(4):265–8.

    CAS  PubMed  Google Scholar 

  145. Choi RY, Jacoby R, Shakoor A. Multimodality ocular imaging in a case report of hyperviscosity syndrome associated with lymphoplasmacytic leukemia: the images tell the story. Retin Cases Brief Rep. 2019 Summer;13(3):238–240.

    Google Scholar 

  146. Macedo MS, Figueiredo AR, Ferreira NN, Barbosa IM, Furtado MJ, Correia NF, Gomes MP, Lume MR, Menéres MJ, Santos MM, Meireles MA. Bilateral proliferative retinopathy as the initial presentation of chronic myeloid leukemia. Middle East Afr J Ophthalmol. 2013;20(4):353–6.

    Google Scholar 

  147. Lureau MA, Glacet-Bernard A, Coscas G. Occlusion de la veine centrale de la rétine bilatérale et anticoagulant circulant [Bilateral central retinal vein occlusion and circulating anticoagulant]. J Fr Ophtalmol. 1995;18(6–7):468–72.

    CAS  PubMed  Google Scholar 

  148. Criswick VG, Schepens CL. Familial exudative vitreoretinopathy. Am J Ophthalmol. 1969;68(4):578–94.

    Article  CAS  PubMed  Google Scholar 

  149. Pendergast SD, Trese MT. Familial exudative vitreoretinopathy Results of surgical management. Ophthalmology. 1998;105(6):1015–102.

    Article  CAS  PubMed  Google Scholar 

  150. Shubert A, Tasman W. Familial exudative vitreoretinopathy: surgical intervention and visual acuity outcomes. Graefes Arch Clin Exp Ophthalmol. 1997;235(8):490–3.

    Article  CAS  PubMed  Google Scholar 

  151. Ikeda T, Fujikado T, Tano Y, et al. Vitrectomy for rhegmatogenous or tractional retinal detachment with familial exudative vitreoretinopathy. Ophthalmology. 1999;106(6):1081–5.

    Article  CAS  PubMed  Google Scholar 

  152. Tagami M, Kusuhara S, Honda S, Tsukahara Y, Negi A. Rapid regression of retinal hemorrhage and neovascularization in a case of familial exudative vitreoretinopathy treated with intravitreal bevacizumab. Graefes Arch Clin Exp Ophthalmol. 2008;246(12):1787–9.

    Article  CAS  PubMed  Google Scholar 

  153. Lin KL, Hirose T, Kroll AJ, Lou PL, Ryan EA. Prospects for treatment of pediatric vitreoretinal diseases with vascular endothelial growth factor inhibition. Semin Ophthalmol. 2009;24:70–6.

    Article  PubMed  Google Scholar 

  154. Buinauskiene J, Buinauskaite E, Valiukeviciene S. Incontinentia pigmenti (bloch-sulzberger syndrome) in neonates. Medicina (Kaunas). 2005;41(6):496–9.

    PubMed  Google Scholar 

  155. Scheuerle A, Ursini MV. Incontinentia pigmenti. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews. Seattle (WA): University of Washington, Seattle;1993.

    Google Scholar 

  156. Goldberg MF, Custis PH. Retinal and other manifestations of incontinentia pigmenti (Bloch-Sulzberger syndrome). Ophthalmology. 1993;100(11):1645–54.

    Article  CAS  PubMed  Google Scholar 

  157. Goldberg MF. The blinding mechanisms of incontinentia pigmenti. Ophthalmic Genet. 1994;15(2):69–76.

    Article  CAS  PubMed  Google Scholar 

  158. Nakao S, Nishina S, Tanaka S, Yoshida T, Yokoi T, Azuma N. Early laser photocoagulation for extensive retinal avascularity in infants with incontinentia pigmenti. Jpn J Ophthalmol. 2020;64(6):613–20.

    Article  CAS  PubMed  Google Scholar 

  159. Nguyen JK, Brady-Mccreery KM. Laser photocoagulation in preproliferative retinopathy of incontinentia pigmenti. J AAPOS. 2001;5(4):258–9.

    Article  CAS  PubMed  Google Scholar 

  160. Wang X, Liang JH. Treatment of retinopathy of incontinentia pigmenti by anti-vascular endothelial growth factor. Zhonghua Yan Ke Za Zhi. 2019;55(4):294–301.

    CAS  PubMed  Google Scholar 

  161. Sims KB. Updated:July 23,2009. NDP-Related Retinopathies. In: GeneReviews at GeneTests: Medical Genetics Information Resource (database online). University of Washington, Seattle;1997–2012. http://www.genetests.org.

  162. Drenser KA, Fecko A, Dailey W, Trese MT. A characteristic phenotypic retinal appearance in Norrie disease. Retina. 2007;27:243–6.

    Article  PubMed  Google Scholar 

  163. Smith SE, Mullen TE, Graham D, Sims KB, Rehm HL. Norrie disease: extraocular clinical manifestations in 56 patients. Am J Med Genet A. 2012.

    Google Scholar 

  164. Chow CC, Kiernan DF, Chau FY, Blair MP, Ticho BH, Galasso JM, Shapiro MJ. Laser photocoagulation at birth prevents blindness in Norrie’s disease diagnosed using amniocentesis. Ophthalmology. 2010;117(12):2402–6.

    Article  PubMed  Google Scholar 

  165. Drenser KA, Walsh MK, Capone A Jr, Trese MT, Luo CK. Preterm treatment of Norrie disease. Ophthalmology. 2011;118(8):1694–5.

    Article  PubMed  Google Scholar 

  166. Walsh MK, Drenser KA, Capone A, Trese MT. Early vitrectomy effective for Norrie disease. Arch Ophthalmol. 2010;128(4):456–60.

    Article  PubMed  Google Scholar 

  167. Kiernan DF, Blair MP, Shapiro MJ. In utero diagnosis of Norrie disease and early laser preserves visual acuity. Arch Ophthalmol. 2010;128(10):1382.

    Article  PubMed  Google Scholar 

  168. Sisk RA, Hufnagel RB, Bandi S, Polzin WJ, Ahmed ZM. Planned preterm delivery and treatment of retinal neovascularization in Norrie disease. Ophthalmology. 2014;121(6):1312–3.

    Article  PubMed  Google Scholar 

  169. Shah VA, Cassell M, Poulose A, Sabates NR. Talc retinopathy. Ophthalmology. 2008;115(4):755-755.e2.

    Article  PubMed  Google Scholar 

  170. Fraser-Bell S, Capon M. Talc retinopathy. Clin Exp Ophthalmol. 2002;30(6):432–3.

    Article  PubMed  Google Scholar 

  171. Martidis A, Yung CW, Ciulla TA. Talc embolism: a static retinopathy. Am J Ophthalmol. 1997;124(6):841–3.

    Article  CAS  PubMed  Google Scholar 

  172. Gedde S, Regillo CD, Vander J. Advanced proliferative retinopathy and iris neovascularization in an intravenous drug abuser. Ophthalmic Surg. 1995;26(1):85–7.

    Google Scholar 

  173. Kresca LJ, Goldberg MF, Jampol LM. Talc emboli and retinal neovascularization in a drug abuser. Am J Ophthalmol. 1979;87(3):334–9.

    Article  CAS  PubMed  Google Scholar 

  174. Ruys J, de Smet MD, Van de Sompel W. Bilateral talc maculopathy and fibrovascular proliferation in a drug abuser. Retin Cases Brief Rep. 2010 Spring;4(2):123–4.

    Google Scholar 

  175. Brucker AJ. Disk and peripheral retinal neovascularization secondary to talc and cornstarch emboli. Am J Ophthalmol. 1979;88(5):864–7.

    Article  CAS  PubMed  Google Scholar 

  176. Tse DT, Ober RR. Talc retinopathy. Am J Ophthalmol. 1980;90(5):624–40.

    Article  CAS  PubMed  Google Scholar 

  177. Monroe AT, Bhandare N, Morris CG, Mendenhall WM. Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys. 2005;61(3):856–64.

    Article  PubMed  Google Scholar 

  178. Durkin SR, Roos D, Higgs B, Casson RJ, Selva D. Ophthalmic and adnexal complications of radiotherapy. Acta Ophthalmol Scand. 2007;85(3):240–50.

    Article  PubMed  Google Scholar 

  179. Mason JO 3rd, Albert MA Jr, Persaud TO, Vail RS. Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma. Retina. 2007;27(7):903–7.

    Article  PubMed  Google Scholar 

  180. Gupta A, Muecke JS. Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin). Retina. 2008;28(7):964–8.

    Article  PubMed  Google Scholar 

  181. Shields CL, Demirci H, Dai V, et al. Intravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanoma. Retina Oct-Nov. 2005;25(7):868–74.

    Article  Google Scholar 

  182. Finger PT, Kurli M. Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol. 2005;89(6):730–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  183. Bianciotto C, Shields CL, Pirondini C, Mashayekhi A, Furuta M, Shields JA. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma. Ophthalmology. 2010 May;117(5):1005–1012.

    Google Scholar 

  184. Hurtikova K, Gerding H. Combined laser photocoagulation and anti-VEGF injection treatment in radiation retinopathy. Klin Monbl Augenheilkd. 2017;234(4):515–519. English.

    Google Scholar 

  185. Seibel I, Vollhardt D, Riechardt AI, Rehak M, Schmied S, Schiller P, Zeitz O, Hellmich M, Joussen AM. Influence of Ranibizumab versus laser photocoagulation on radiation retinopathy (RadiRet)—a prospective randomized controlled trial. Graefes Arch Clin Exp Ophthalmol. 2020;258(4):869–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dobry Wzrok Ophthalmological Clinic, Żabi Kruk 10, 80-822, Gdańsk, Poland

    Maciej Gawęcki

  2. Department of Ophthalmology, Specialist Hospital in Chojnice, 89-600, Leśna 10, Chojnice, Poland

    Maciej Gawęcki

  3. Department of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland

    Andrzej Grzybowski

  4. Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznan, Poland

    Andrzej Grzybowski

Authors
  1. Maciej Gawęcki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrzej Grzybowski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maciej Gawęcki .

Editor information

Editors and Affiliations

  1. Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznan, Poland

    Andrzej Grzybowski

  2. Ventura County Retinal Vitreous Medical Group, Ventura, CA, USA

    Jeffrey K. Luttrull

  3. Vitreoretinal Surgeon and Clinical Lead, Moorfields Eye Hospital, Abu Dhabi, United Arab Emirates

    Igor Kozak

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gawęcki, M., Grzybowski, A. (2023). Ischemic Peripheral Retinopathies. In: Grzybowski, A., Luttrull, J.K., Kozak, I. (eds) Retina Lasers in Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-031-25779-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-25779-7_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-25778-0

  • Online ISBN: 978-3-031-25779-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation